安定
发表于 2025-3-28 17:02:42
http://reply.papertrans.cn/43/4213/421296/421296_41.png
AVERT
发表于 2025-3-28 22:13:02
http://reply.papertrans.cn/43/4213/421296/421296_42.png
配置
发表于 2025-3-28 23:56:51
http://reply.papertrans.cn/43/4213/421296/421296_43.png
种属关系
发表于 2025-3-29 03:35:38
https://doi.org/10.1007/978-3-7091-5323-9nd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.
Inferior
发表于 2025-3-29 10:06:52
http://reply.papertrans.cn/43/4213/421296/421296_45.png
典型
发表于 2025-3-29 12:17:32
http://reply.papertrans.cn/43/4213/421296/421296_46.png
dendrites
发表于 2025-3-29 16:21:30
Spine, early data suggest that stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Dose limiting toxicities and treatment precision are ongoing areas of controversy and investigation.
APO
发表于 2025-3-29 21:20:21
Lungnd large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.
清唱剧
发表于 2025-3-30 01:38:47
Digestive System organs, dose limiting toxicity remains the primary impediment to treatment, but advances in targeting and tracking precision have improved outcomes over recent years. Greater advances may be achieved in the coming years through the combination of stereotactic body radiotherapy with systemic chemotherapy or targeted molecular agents.